Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
J Chen, L Jian, Y Guo, C Tang, Z Huang, J Gao - Antioxidants, 2024 - mdpi.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one-
third of the global population. MASLD and its advanced-stage liver fibrosis and cirrhosis are …
third of the global population. MASLD and its advanced-stage liver fibrosis and cirrhosis are …
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue
The development of steatotic liver disease after liver transplant (LT) is widely described, and
epidemiological data have revealed an increased incidence in recent times. Its evolution …
epidemiological data have revealed an increased incidence in recent times. Its evolution …
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
NWS Chew, XH Pan, B Chong, C Chandramouli… - Diabetes Research and …, 2024 - Elsevier
The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension,
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …
hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases …
Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
N Tamaki, T Kimura, SI Wakabayashi… - Alimentary …, 2024 - Wiley Online Library
Background A multi‐society consensus group proposed a new nomenclature for steatotic
liver disease (SLD) including metabolic‐dysfunction associated steatotic liver disease …
liver disease (SLD) including metabolic‐dysfunction associated steatotic liver disease …
Low thyroid function is associated with metabolic dysfunction‐associated steatotic liver disease
S Wang, D Xia, H Fan, Z Liu, R Chen, C Suo… - JGH …, 2024 - Wiley Online Library
Abstract Background and Aim Metabolic dysfunction‐associated steatotic liver disease
(MASLD) is recently introduced to better highlight the pathogenic significance of …
(MASLD) is recently introduced to better highlight the pathogenic significance of …
Systemic metabolic Abnormalities: Key drivers of complications and mortality in MASLD
X Fan, B Zhang, Y Shi, L Liu… - Journal of Hepatology, 2024 - journal-of-hepatology.eu
Metabolic dysfunction-associated steatotic liver disease (MASLD), as a new term that
includes hepatic steatosis and cardiometabolic risk factors, has triggered numerous clinical …
includes hepatic steatosis and cardiometabolic risk factors, has triggered numerous clinical …
The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis
Aim Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) are at
increased risk of incident cardiovascular disease. However, the clinical characteristics and …
increased risk of incident cardiovascular disease. However, the clinical characteristics and …
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated …
Y Min, X Wei, Z Wei, G Song, X Zhao, Y Lei - Cardiovascular Diabetology, 2024 - Springer
Backgrounds Insulin resistance (IR) plays a vital role in the pathogenesis of the metabolic
dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear …
dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear …
A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of …
PC Ma, QM Li, RN Li, C Hong, H Cui… - Frontiers in …, 2024 - frontiersin.org
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD)
poses a considerable health risk. Nevertheless, its risk factors are not thoroughly …
poses a considerable health risk. Nevertheless, its risk factors are not thoroughly …
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic …
Background and aims Metabolic dysfunction associated steatotic liver disease (MASLD)
increases the risk of incident chronic kidney disease (CKD). However, the relative risk of …
increases the risk of incident chronic kidney disease (CKD). However, the relative risk of …